Global Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis - 2018

  • ID: 4516504
  • Report
  • Region: Global
  • Fore Pharma
1 of 3
The researcher announced the results of its Age-Related Macular Degeneration patients study in a new research ‘Global Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis - 2018’. The research provides insights into Age-Related Macular Degeneration epidemiology, Age-Related Macular Degeneration diagnosed patients, and Age-Related Macular Degeneration treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Age-Related Macular Degeneration derived from epidemiological analysis, patients diagnosed with Age-Related Macular Degeneration, and patients treated with a drug therapy.

The research study helps executives estimate Age-Related Macular Degeneration market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Age-Related Macular Degeneration prevalence, Age-Related Macular Degeneration diagnosis rate, and Age-Related Macular Degeneration treatment rate for the period 2017 - 2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features of the Report:
  • Age-Related Macular Degeneration Patient Flow
  • Age-Related Macular Degeneration Prevalence
  • Age-Related Macular Degeneration Diagnosed Patients
  • Age-Related Macular Degeneration Treated Patients
Note: Product cover images may vary from those shown
2 of 3
1. Age-Related Macular Degeneration: Disease Definition
2. Global Age-Related Macular Degeneration Patient Flow
2A. Global Age-Related Macular Degeneration Prevalence
2B. Global Age-Related Macular Degeneration Diagnosed Patients
2C. Global Age-Related Macular Degeneration Treated Patients
3. Age-Related Macular Degeneration Patient Flow in the US
3A. Age-Related Macular Degeneration Prevalence in the US
3B. Age-Related Macular Degeneration Diagnosed Patients in the US
3C. Age-Related Macular Degeneration Treated Patients in the US
4. Age-Related Macular Degeneration Patient Flow in Europe
4A. Age-Related Macular Degeneration Prevalence in Europe
4B. Age-Related Macular Degeneration Diagnosed Patients in Europe
4C. Age-Related Macular Degeneration Treated Patients in Europe
5. Age-Related Macular Degeneration Patient Flow in Germany
5A. Age-Related Macular Degeneration Prevalence in Germany
5B. Age-Related Macular Degeneration Diagnosed Patients in Germany
5C. Age-Related Macular Degeneration Treated Patients in Germany
6. Age-Related Macular Degeneration Patient Flow in France
6A. Age-Related Macular Degeneration Prevalence in France
6B. Age-Related Macular Degeneration Diagnosed Patients in France
6C. Age-Related Macular Degeneration Treated Patients in France
7. Age-Related Macular Degeneration Patient Flow in Spain
7A. Age-Related Macular Degeneration Prevalence in Spain
7B. Age-Related Macular Degeneration Diagnosed Patients in Spain
7C. Age-Related Macular Degeneration Treated Patients in Spain
8. Age-Related Macular Degeneration Patient Flow in Italy
8A. Age-Related Macular Degeneration Prevalence in Italy
8B. Age-Related Macular Degeneration Diagnosed Patients in Italy
8C. Age-Related Macular Degeneration Treated Patients in Italy
9. Age-Related Macular Degeneration Patient Flow in UK
9A. Age-Related Macular Degeneration Prevalence in UK
9B. Age-Related Macular Degeneration Diagnosed Patients in UK
9C. Age-Related Macular Degeneration Treated Patients in UK
10. Age-Related Macular Degeneration Patient Flow in Japan
10A. Age-Related Macular Degeneration Prevalence in Japan
10B. Age-Related Macular Degeneration Diagnosed Patients in Japan
10C. Age-Related Macular Degeneration Treated Patients in Japan
11. Research Methodology

List of Tables
Table 1: Global Age-Related Macular Degeneration Patient Flow, 2017
Table 2: Global Age-Related Macular Degeneration Patient Flow Forecast, 2017 - 2026
Table 3: Age-Related Macular Degeneration Patient Flow in the US, 2017
Table 4: Age-Related Macular Degeneration Patient Flow Forecast in the US, 2017 - 2026
Table 5: Age-Related Macular Degeneration Patient Flow in Europe, 2017
Table 6: Age-Related Macular Degeneration Patient Flow Forecast in Europe, 2017 - 2026
Table 7: Age-Related Macular Degeneration Patient Flow in Germany, 2017
Table 8: Age-Related Macular Degeneration Patient Flow Forecast in Germany, 2017 - 2026
Table 9: Age-Related Macular Degeneration Patient Flow in France, 2017
Table 10: Age-Related Macular Degeneration Patient Flow Forecast in France, 2017 - 2026
Table 11: Age-Related Macular Degeneration Patient Flow in Spain, 2017
Table 12: Age-Related Macular Degeneration Patient Flow Forecast in Spain, 2017 - 2026
Table 13: Age-Related Macular Degeneration Patient Flow in Italy, 2017
Table 14: Age-Related Macular Degeneration Patient Flow Forecast in Italy, 2017 - 2026
Table 15: Age-Related Macular Degeneration Patient Flow in UK, 2017
Table 16: Age-Related Macular Degeneration Patient Flow Forecast in UK, 2017 - 2026
Table 17: Age-Related Macular Degeneration Patient Flow in Japan, 2017
Table 18: Age-Related Macular Degeneration Patient Flow Forecast in Japan, 2017 - 2026

List of Figures
Figures 1: Global Age-Related Macular Degeneration Patient Flow, 2017
Figure 2: Global Age-Related Macular Degeneration Patient Flow Forecast, 2017 - 2026
Figure 3: Age-Related Macular Degeneration Patient Flow in the US, 2017
Figure 4: Age-Related Macular Degeneration Patient Flow Forecast in the US, 2017 - 2026
Figure 5: Age-Related Macular Degeneration Patient Flow in Europe, 2017
Figure 6: Age-Related Macular Degeneration Patient Flow Forecast in Europe, 2017 - 2026
Figure 7: Age-Related Macular Degeneration Patient Flow in Germany, 2017
Figure 8: Age-Related Macular Degeneration Patient Flow Forecast in Germany, 2017 - 2026
Figure 9: Age-Related Macular Degeneration Patient Flow in France, 2017
Figure 10: Age-Related Macular Degeneration Patient Flow Forecast in France, 2017 - 2026
Figure 11: Age-Related Macular Degeneration Patient Flow in Spain, 2017
Figure 12: Age-Related Macular Degeneration Patient Flow Forecast in Spain, 2017 - 2026
Figure 13: Age-Related Macular Degeneration Patient Flow in Italy, 2017
Figure 14: Age-Related Macular Degeneration Patient Flow Forecast in Italy, 2017 - 2026
Figure 15: Age-Related Macular Degeneration Patient Flow in UK, 2017
Figure 16: Age-Related Macular Degeneration Patient Flow Forecast in UK, 2017 - 2026
Figure 17: Age-Related Macular Degeneration Patient Flow in Japan, 2017
Figure 18: Age-Related Macular Degeneration Patient Flow Forecast in Japan, 2017 - 2026
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll